Doug Hampton PLYMOUTH MEETING, Pa., Feb. 2, 2024 /PRNewswire/ — INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it has made an equity grant to a newly hired employee under its 2022 Inducement Plan (the “Inducement Plan”). The Compensation … Read more
Removing Subjectivity from the Gym and Clinic: When Force, Top Performance, and Recovery Matters, the Numbers Don’t Lie WESTBROOK, Maine, Feb. 1, 2024 /PRNewswire/ — Today Hawkin Dynamics, an innovative, venture-backed pioneer in the sports and physical rehabilitation technology sector, announced the launch of their second product available direct-to-consumer, Hawkin TruStrength. “We are thrilled to launch the … Read more
OMAHA, Neb., Jan. 31, 2024 /PRNewswire/ — Heritage Management Services is pleased to announce its newest venture in collaboration with American Healthcare REIT. Beginning March 1, Heritage Management Services will take the reins as the management company for two Omaha-area communities, Ridgewood and Fountain View, totaling 221 apartments. Ridgewood, located in Bennington, NE, has been … Read more
SHANGHAI, Jan. 30, 2024 /PRNewswire/ — WuXi XDC (2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on ADC and the other types of bioconjugate market; and Multitude Therapeutics, a clinical stage biotechnology company renowned for ADC platform technologies, announced today that they have reached a comprehensive partnership in drug-linker technology, which … Read more
JINAN, China, Jan. 30, 2024 /PRNewswire/ — The interim analysis results from the phase III INSPIRE study of iruplinalkib developed by Qilu Pharmaceutical, which focuses on the first-line treatment of locally advanced or metastatic anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC), have recently been featured in the Journal of Thoracic Oncology (Impact Factor=20.4), the … Read more
COLUMBUS, Ohio, Jan. 29, 2024 /PRNewswire/ — Candid, the company behind the revolutionary CandidPro clear aligner system, is opening 2024 with two more significant additions to its already impressive Candid Academy Faculty. David Little, DDS, and John Flucke, DDS, have agreed to bring their expertise and support to CandidPro. With these two industry powerhouses on board, … Read more
DUBAI, UAE, Jan. 28, 2024 /PRNewswire/ — Estonia, renowned for its cutting-edge healthcare research and development, is set to make a significant mark at Arab Health 2024, showcasing its expertise and collaboration opportunities to the GCC region. Estonia’s Digital Health Triumph Shines at Arab Health 2024: E-health Sector Soars with 100% Turnover Growth (PRNewsfoto/Enterprise Estonia) … Read more
TAMPA, Fla., Jan. 27, 2024 /PRNewswire/ — Thyroid Disease Awareness Month (January) is a pivotal time for raising awareness about the pros and cons of thyroid surgery—one of the most common operations performed in the US. Unfortunately, about 20% of patients having a thyroid operation have something go wrong, resulting in a less than desirable … Read more
NEW ORLEANS, Jan. 26, 2024 /PRNewswire/ — Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Ambrx Biopharma, Inc. (NasdaqGS: AMAM) to Johnson & Johnson (NYSE: JNJ). Under the terms of the proposed transaction, shareholders of Ambrx … Read more
AMSTERDAM, 26. Januar 2024 /PRNewswire/ — Das Critical Path Institute (C-Path) hat Dr. Klaus Romero, M.D., M.S., FCP, zu seinem neuen geschäftsführenden Direktor ernannt und Cécile Ollivier, M.S., von Managing-Direktorin, Europa, zur Vizepräsidentin für globale Angelegenheiten befördert. Klaus Romero, M.D., M.S., FCP, Chief Executive Officer, Critical Path Institute Cécile Ollivier, M.S., Vice President of Global … Read more